Pharma firms to be incentivised to develop new superbug drugs

Share this post

Health secretary Matt Hancock set to announce plans at World Economic Forum in Davos

The government is set to incentivise pharmaceutical companies to develop “urgently needed” drugs to fight antimicrobial resistant (AMR) superbugs, with the health secretary set to warn “we are on the cusp of a world where a simple graze could be deadly”.

Under the plans, the inappropriate use of antibiotics would also be cut by 15%, reducing resistant infections and potentially saving thousands of lives in the UK.

Continue reading…

This post was syndicated from Health | The Guardian. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply